studies of types A, B, and E botulinal toxins by passive hemagglutination and bentonite flocculation. J. Bacteriol. 91:967-974. 1966.-Formalinized sheep red blood cells (SRBC), sensitized with types A, B, and E botulinal toxoids and toxins by bis-diazotized benzidine (BDB), were tested against A, B, and E antitoxins prepared in horses and rabbits. Type B antitoxin cross-reacted with A toxoid SRBC, but the reciprocal cross-reaction was not observed. E toxin SRBC were specifically agglutinated by E antitoxin. Flocculation of antigen-sensitized bentonite particles was less sensitive in titration of antitoxin than hemagglutination. Also, reciprocal cross-reactions were observed between types A and B antitoxins. Cross-reactions in both serological tests were eliminated by titration of antitoxins in the presence of the heterologous antigens, with no inhibitory effect on the homologous antitoxins. Generally, equine antitoxins were less suitable for agglutinations, especially of antigen-sensitized bentonite particles. Types A, B, and E antitoxins were specifically inhibited by 43, 39, and 245 
There are at least six types of antigenically distinct Clostridium botulinum toxins distinguishable by animal protection tests. These botulinal toxins are designated A, B, C, D, E, and F (7) . The antigenic specificity of these toxins may not be as clear and distinct when in vitro serological tests are used. Studies by Lamanna and Lowenthal (11) have shown, for example, that cross-precipitation occurs between type A botulinal toxin and type B antitoxin. Also, antiserum produced to type A toxin neutralizes the hemagglutinin of type B toxin. Conversely, antiserum to type B toxin neutralizes the hemagglutinin of type A toxin. Reports by Rycaj (14) , Yafayer and Chepeler (18) , and Sinitsyn (15) indicate that passive hemagglutination of botulinal antitoxin-coated, tanned sheep red blood cells (SRBC) by toxins is as sensitive in detecting botulinal toxins as animal assay. Rycaj, however, worked only with type A toxin, whereas Yafayer and Chepeler, working with both A and B toxins, could not distinguish between them. Sinitsyn was able to distinguish between the two toxins, but the potencies of the toxins used in his studies were much lower than those usually found with botulinal cultures. None of these investigators used antigen-sensitized SRBC in their investigations. A recent review by Petty (12) includes references to the passive hemagglutination procedures just described.
The present study was initiated in an effort to JOHNSON ET AL.
increase understanding of the in vitro serological properties of types A, B, and E botulinal toxins, and with the hope of development of an in vitro serological test for the specific detection of botulinal toxins in cultures and contaminated foods. The serological tests used for these studies were hemagglutination and bentonite flocculation.
MATERIALS AND METHODS
Reagents. Trypsin used in these studies was Difco 1:250. Fisher reagents were used to prepare 0.15 M phosphate-buffered saline, pH 7.2 (PBS; 16). Fisher reagents were also used to prepare 0.15 M phosphate buffer, pH 7.3 (PB; 10). Bovine serum albumin fraction V powder (BSA) was obtained from Nutritional Biochemicals Corp., Cleveland, Ohio. Solutions of 1 and 0.25% were prepared in PBS. Bis-diazotized benzidine (BDB) was prepared according to the method of Gordon et al. (10) .
Sources of purified toxins Preparation of partially purified type E toxin for sensitization of erythrocytes and bentonite particles. The VH strain of C. botulinum type E was grown in a cellophane bag that was constructed as described by Boroff (1). The toxin-production medium was prepared as described by Gordon et al. (9) . The inoculum, 2 ml of an 18-hr culture, was added to 100 ml of physiological saline in the cellophane bag. The culture was incubated at 30 C for 7 days, after which the cellophane bag was removed from the medium and the contents were centrifuged at 15,000 rev/min for 1 hr in the International BD-2-ultracentrifuge (970 rotor). A and B botulinal toxins were diluted in phosphatebuffered gelatin (pH 6.5). The buffer-gelatin solution was prepared as described by Crisley (6) . Six mice, weighing 20 g each, were injected intraperitoneally with 0.5 ml of each dilution of toxin. Deaths were recorded at the end of 4 days, and LD50 values were determined by the method of Reed and Muench (13) . Type E toxin was diluted 1:10 in 0.1 M phosphate buffer (pH 6.5) containing a final concentration of 0.1% trypsin. The toxin and trypsin were incubated at 37 C for 60 min, after which the trypsin-treated toxin was diluted in phosphate-buffered gelatin (pH 6.5) and injected into mice.
Botulinal antitoxins. Types A, B, and E equine antitoxins were obtained from the Communicable Disease Center (CDC), Atlanta, Ga. The stock antitoxins contained 10 international units (IU) of antitoxin per ml (2) . Type E equine antitoxin was also obtained from the Microbiological Research Establishment, Porton, England. The Porton antitoxin contained 1,500 IU of antitoxin per ml.
Types A, B, and E antitoxins were also produced in rabbits by repeated intraperitoneal injections of A, B, and E botulinal toxoids in complete Freund's adjuvant. Two rabbits were injected with 2 mg of each toxoid biweekly for 13 weeks. The rabbits were bled 3 weeks after the final injection by cardiac puncture. Samples of the sera were stored at -20 C. Prior to use in serological tests, the sera were inactivated at 56 C for 30 min. Before use in hemagglutination procedures, all sera were absorbed with equal volumes of packed SRBC. Antisera to the individual toxoids had similar potency in in vitro tests. The potency of the E antitoxin produced in one rabbit was found to be 18 IU per ml, with Porton equine antitoxin as reference (2) . Standard antitoxins to A and B toxins were not available; therefore, the potencies of rabbit types A and B antitoxins were not expressed in terms of international units.
Formaldehyde treatment of erythrocytes. The method of Butler (5) was employed for formalinization of SRBC. The formalinized SRBC were stored at 4 C as a 50% suspension in PBS. The final cell suspension contained 0.01% thimerosal.
Coupling ofantigens to formalinized SRBC by BDB. Toxoids and toxins were coupled to SRBC by modification of the procedure described by Butler (5) . A 0.1-ml amount of a 50% suspension of formalinized SRBC was added to toxoid (or toxin) contained inVOL. 91, 1966 SEROLOGY OF BO] mixture of toxoid and SRBC. The mixture was incubated at room temperature for 12 min, followed by centrifugation of the mixture at 2,500 rev/min for several minutes to sediment the cells. The cells were washed twice with PB and resuspended to 2.5 ml with 0.25% BSA. Thimerosal was added to a final concentration of0.01% if the cells were not used immediately. The optimal concentrations of types A and B toxoids for sensitization of cells were, respectively, 100 and 200 MAg of toxoid per ml. Partially purified type E toxin at a concentration of 100,000 LD6o per ml was used for sensitization of formalinized SRBC for hemagglutination by E antitoxin. Type E toxoid was not used for sensitization of SRBC because of contamination with trypsin. The toxoid was prepared according to the method of Gordon et al. (9) , which included trypsin activation in the purification procedure. Rabbits immunized with the toxoid produced, along with antitoxin, potent antibodies to the trypsin, which masked the toxin-antitoxin reaction. The toxins and toxoids used for sensitization of cells were devoid of hemagglutinating activity at concentrations used.
Hemagglutination of antigen-sensitized formalinized SRBC by antitoxin. Hemagglutinations wese carried out by serial twofold dilution of antisera in 0.5-ml volumes in 0.25% BSA. To each dilution of antiserum was added 0.05 ml of antigen-sensitized formalinized SRBC. The mixture was shaken, incubated at room temperature for 4 to 18 hr, and then read for agglutination by pattern formation. The titer was considered as the highest dilution of antitoxin that produced unequivocal clumping of the cells.
Hemagglutination-inhibition tests. Hemagglutination-inhibition tests were performed by mixing various concentrations of toxin from toxic cultures in 0.25-ml quantities in 0.25% BSA with 0.25 ml of antitoxin that had been diluted with 0.25% BSA to contain a three-plus hemagglutinating dose of antitoxin. After the mixtures had incubated for 20 min at room temperature, antigen-sensitized formalinized SRBC were added. The contents were mixed, incubated at room temperature for 4 to 18 hr, and read for pattern development.
Preparation of antitoxin-sensitized formalinized SRBC. To 1 ml of rabbit antitoxin that had been diluted to 10 ml with distilled water was added 5 ml of a saturated solution of (NH4)2SO4. The globulin was collected by centrifugation at 2,400 rev/min for 15 min, after which it was dissolved in 5 ml of PBS and dialyzed against several changes of PBS. The dialyzed antitoxin globulin was then cleared of particulate matter by centrifugation at 15,000 rev/min for 30 min. The cleared antitoxin globulin was measured in a Beckman DU spectrophotometer at a wavelength of 278 m,. The antitoxin globulin was coupled to formalinized SRBC by 1.5 ml of diluted BDB as described for antigen coupling. The antitoxin-sensitized cells were suspended in 2.5 ml of 0.25% BSA.
Hemagglutination of antitoxin-sensitized formalinized SRBC by botulinal toxins. Crystalline type A botulinal toxin and botulinal toxins removed from cultures by acid or (NH4)2SO4 precipitation were serially diluted in 0.5-ml volumes in 0.25% BSA. To each dilution of toxin was added 0.05 ml ol antitoxin-TULINAL TOXINS 969 sensitized formalinized SRBC. The tubes were incubated and the test was read as described for hemagglutination of antigen-sensitized cells by antitoxin. Controls consisted of a tube of the highest concentration of toxin used in the test with untreated formalinized SRBC (2.5% solution) and a tube containing antitoxin-sensitized formalinized SRBC and 0.25% BSA.
Flocculation ofantigen-sensitized bentonite particles. Stock bentonite (Volclay, American Colloid Co., Skokie, Ill.) was prepared by the method of Bozicevich et al. (3) . Bentonite particles were sensitized with types A and B botulinal toxoids and partially purified type E toxin by a modification of the method of Wolff et al. (17) . To 10 ml of stock bentonite suspension that had been concentrated to 1 ml in distilled water by centrifugation was added 1 ml of toxoid or toxin containing 500 to 1,000 Ag of types A and B toxoids and 100,000 LDbo of E toxin. After incubation of bentonite and antigen for 1 hr at room temperature, 1 ml of 1% BSA, 15 ml of distilled water, and 0.1 ml of 1% methylene blue were added. The antigen-sensitized bentonite particles were centrifuged and washed twice with 1 ml of 1% BSA and 15 ml of distilled water. The bentonite particles were suspended in 1% BSA to a final concentration of 150,000 particles per mm3. For the test, serum was serially diluted in 0.1-ml volumes in PBS on microflocculation slides. To each dilution of serum was added 0.05 ml of antigensensitized bentonite. The mixture was rotated at 120 rev/min on a variable-speed rotator (Yankee-type from Clay-Adams Inc., New York, N.Y.) for 20 min, after which the antigen-coated bentonite particles were examined for clumping under a microscope at 100 times magnification.
Bentonite flocculation inhibition. Bentonite flocculation inhibitions were performed by serial dilution of the acid-and (NH4)2SO4-precipitated toxins in 0.1-ml volumes in tubes (10 by 75 mm). To each dilution of toxin was added 0.1 ml of antitoxin. The antitoxin had been diluted to contain a three-plus agglutinating dose of antitoxin in 0.1 ml after having been mixed with the toxin. After incubating at room temperature for 20 min, 0.1 ml of each dilution of the mixture of inhibitor and antitoxin was added to microflocculation slides, and bentonite flocculation was carried out as described above.
Flocculation of antibody-sensitized bentonite parti- Table 3 . The rabbit antitoxins are the same as those used in the hemagglutinations reported in Tables 1 and 2 The acid-and (NH4)2SO4-precipitated toxins were employed against a three-plus hemagglutinating dose of antitoxin. Types b Values represent the smallest amount of toxin (in 0.25 ml) in terms of LD50 that completely inhibited a three-plus agglutinating dose of antitoxin or the largest amount of toxin that had no effect on antitoxin.
c Hemagglutination patterns were recorded as described by Butler (5) . This scheme of notation also holds for hemagglutination recordings in Tables 5 and 7. inhibitory properties in either the hemagglutination or bentonite flocculation procedures.
The toxins that were used for inhibitions in Tables 3 and 4 were also used for hemagglutination of types A and B antitoxin-sensitized SRBC ( Table 5 ). The rabbit antitoxins that were employed in the hemagglutinations and bentonite flocculations summarized in Table 2 were also employed for sensitization of formalinized SRBC. Equine antitoxins from the CDC were unsuitable for antibody sensitization of SRBC. SRBC were sensitized with 100 and 200 ug of antitoxin globulin per ml. Type A botulinal toxin was detected in quantities as low as 1. Table 6 . The specificity of the reactions depended on the amount of antitoxin globulin used for sensitization of the bentonite. For example, strong crossreactions occurred in both systems when 5,000 Mug of antitoxin was used for sensitization of the bentonite particles. When 500 Mug of antitoxin globulin was used for sensitization, type A toxin could be specifically detected in quantities as low as 140 mouse LD5o per 0.1 ml and type B toxin at 630 LD5o per 0.1 ml. Supernatant fluids from cultures of an enterococcus, Micrococcus, and Bacillus species, and from one strain each of C. botulinum type E, C. perfringens, C. sporogenes, C. bifermentans, C. butyricum, C. multifermentans, C. putrefaciens, and C. tetani did not clump either A antitoxin-or B antitoxin-sensitized SRBC or bentonite particles. The antitoxin-sensitized SRBC and bentonite techniques were not success- b Values represent the smallest amount of toxin (in 0.1 ml) in terms of LD50 that completely or partially inhibited a three-plus agglutinating dose of antitoxin or the largest amount of toxin used that had no effect on antitoxin.
c Bentonite flocculations were recorded as described by Bozicevich et al. (3) . This scheme of notation also holds for flocculation recordings in Hemagglutination inhibition and bentonite flocculation inhibition appear to be quite suitable for the rapid and specific detection of botulinal toxins types A, B, and E in cultures and foods. Hemagglutination inhibition detects toxin at levels well below that which is fatal to human beings.
The antitoxin-sensitized SRBC technique is extremely sensitive, detecting toxins at levels of less than one to several LD50 per 0.5 ml. The strong cross-reaction of B antitoxin-SRBC with A toxin does not hinder the differential diagnostic potential of this test, since no cross-reaction occurred between A antitoxin SRBC and type B botulinal toxin. With the use of the same antitoxins, antitoxin-bentonite flocculation was considerably less sensitive than hemagglutination, detecting 140 mouse LD5o per 0.1 ml of A toxin and 630 LD50 of B toxin. The potency of CDC equine antitoxins, in terms of serum dilutions, was considerably less than that of rabbit antitoxins types A and B. This lower potency may account for the inability of CDC equine antitoxins to sensitize SRBC and bentonite particles. The inability of rabbit type E antitoxin to work in the antitoxin SRBC test may also be due to low antibody content of the serum. The hemagglutination titer of rabbit type E antitoxin was considerably lower than that of rabbit types A and B antitoxins.
The diagnostic equine antitoxins presently available to botulinal toxins may not be the most suitable for in vitro serological studies of botulinal toxins. This observation is based on the unsuitability of equine types A and B antitoxins (CDC) to sensitize SRBC and bentonite particles and the inability of equine type E antitoxin (CDC) to clump either antigen-sensitized SRBC or bentonite particles.
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